Conexeu Sciences Inc. Common Stock (CNXU)

• Market cap: $352M
• 1 day: 19.26%
• 5 days: 18.42%
• 1 month: 28.84%
• 3 months: 28.84%
• 6 months: 28.84%
• Year to date: 28.84%
• 1 year: 28.84%
• 5 years: 28.84%
• 10 years: 28.84%
• Sector: Healthcare
• Industry: Biotechnology

About: Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.